Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal hyoscine butylbromide versus misoprostol for cervical ripening before gynecological intrauterine procedures
IRCT20151228025732N68Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of hyoscine butylbromide and misoprostol in Cervical insufficiency (CI) (2 arms), sponsored by Semnan University of Medical Sciences. Primary endpoints: Cervical diameter, Pain amount and 1 more. Started May 2021; status: completed.
02
Drugs
hyoscine butylbromidemisoprostol
03
Conditions
Cervical insufficiency (CI)
Beyond the preview
Go deeper on IRCT20151228025732N68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151228025732N68.